HOME >> MEDICINE >> NEWS
A drug's brand name skews patient treatment choices

The brand name of a drug can strongly influence treatment decisions by patients, according to a randomized trial of decision aids by researchers from McMaster University.

The unexpected finding regarding the strong influence that drug names have on treatment choices emerged from a study undertaken by Dr. Anne Holbrook and McMaster colleagues who wanted to see if certain features of a decision aid i.e., format and graphic presentation of data on benefits and harms of treatment options make a difference. They designed a decision aid for anticoagulant drug therapy for atrial fibrillation in 3 formats (decision board, decision booklet with audiotape, or interactive computer program) with 2 types of data presentation (pie graph or pictogram). The treatment options were identified initially as "treatment A" (warfarin), "treatment B" (acetylsalicylic acid) and "treatment C" (no treatment). The authors found that the participants comprehension of the condition and treatment options improved significantly with the decision aid, regardless of the format or graphic presentation of data. Virtually all (96%) of the participants felt that the decision aid helped them make their treatment choice.

But unexpectedly, they also discovered that after participants were shown the true treatment names, 36% changed their initial choice (including 46% of those who initially chose warfarin and 78% of those who initially chose no treatment), even though the risks and benefits of each treatment were clearly laid out in the decision aid.

In a related commentary, Dr. Annette O'Connor notes that many common medical decisions exist in a "grey zone," where the best choice differs depending on how patients weigh the benefits and risks of each treatment option. She discusses how patient decision aids differ from educational aids and how they help patients and express their personal values.


'"/>

Contact: Dr. Anne Holbrook
905-525-9140 x22169
Canadian Medical Association Journal
21-May-2007


Page: 1

Related medicine news :

1. Chemical maps hint at drugs effects on schizophrenia
2. Study to test drugs potential to preserve insulin production in newly diagnosed type 1 diabetics
3. Anti-inflammatory drugs potentially deadly side effect found to be rare
4. Trial demonstrates new drugs effectiveness against psoriasis
5. Young childrens taste preferences may be influenced by fast-food branding
6. MRI shows brains respond better to name brands
7. Mega-brands have mega influence on dietary behavior
8. Alcohol-branded merchandise associated with early teen drinking
9. Brain-scanning technology reveals how we process brands and products
10. Where your brain wires itself to like (name your favorite brand)
11. Health benefits of a Christmas brandy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/20/2017)... ... August 20, 2017 , ... ... ComplyPAK™ Compliance Management System has assisted multiple clients in successfully passing audits ... Service Organization Control Level 2 (AICPA SOC Level 2), and State Data Use ...
(Date:8/19/2017)... ... ... Western University of Health Sciences will host a special symposium and exhibition about ... on Wednesday, September 6, 2017. , The symposium will be from noon to 1 ... from 1 to 3 p.m. showcasing virtual reality education technology, high speed 3-D printing ...
(Date:8/19/2017)... ON (PRWEB) , ... August 19, 2017 , ... Curl ... the of NaturallyCurly.com® The Curl Leaders, Editors’ Choice 2017 Award for the second year ... accessory for hair stylists and curlies alike was voted Best Moisturizer for Type 2 ...
(Date:8/19/2017)... ... August 19, 2017 , ... ... joined its Orlando location as an interventional pain management physician. He brings a ... the treatment of migraine headaches, and significant experience in spinal cord stimulation for ...
(Date:8/18/2017)... ... August ... ... For Immediate Release                Contact: Julian Teixeira, August 18, ... Sex and Relationship Advice from their Fathers , Contrary ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... 15, 2017   Mostyn Law and Gulf Coast Regional ... Texas . The Mostyn Law family has had ... That is why Mostyn Law is partnering with Gulf ... show its appreciation. Blood supplies are running low. Gulf ... of hospital needs in August. That is why the blood center ...
(Date:8/15/2017)... WILMINGTON, N.C. , Aug. 15, 2017 ... Wilmington, NC , today announced that the company ... at the University of North Carolina at Chapel Hill ... AccuKit-HIV is designed to characterize and quantify HIV reservoir ... and after pharmacological intervention. The HIV Cure Center is ...
(Date:8/11/2017)... DarioHealth Corp. (NASDAQ: DRIO), a leading global ... solutions, today announced that it will release its second ... a conference call at 9:00am ET. The Company will ... and its strategy and outlook for the remainder of ... Raphael , Chief Executive Officer, and Zvi Ben-David ...
Breaking Medicine Technology:
Cached News: